Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Tag”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05937672
What this trial is testing

Cold Atmospheric Plasma Device Extension Study

Who this might be right for
Verruca VulgarisMolluscum Contagiosum
Medical University of South Carolina 60
Large-scale testing (Phase 3)UnknownNCT01622361
What this trial is testing

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 290
Large-scale testing (Phase 3)Active Not RecruitingNCT04739761
What this trial is testing

T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 506
Testing effectiveness (Phase 2)Study completedNCT02491983
What this trial is testing

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
MedSIR 486
Early research (Phase 1)Active Not RecruitingNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 291
Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186
What this trial is testing

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 1,000
Large-scale testing (Phase 3)Study completedNCT00257205
What this trial is testing

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Who this might be right for
Melanoma
AstraZeneca 655
Early research (Phase 1)WithdrawnNCT06411639
What this trial is testing

Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Who this might be right for
Sjogren DiseaseSystemic Lupus Erythematosus
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT01395706
What this trial is testing

ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes

Who this might be right for
Malignant Neoplasm of Breast
Pulsion Medical Systems SE 125
Post-approval studies (Phase 4)Study completedNCT00509990
What this trial is testing

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Testing effectiveness (Phase 2)UnknownNCT00381368
What this trial is testing

Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Turku 60
Testing effectiveness (Phase 2)Study completedNCT00725439
What this trial is testing

An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne

Who this might be right for
Acne
Stiefel, a GSK Company 16
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Not applicableLooking for participantsNCT06050109
What this trial is testing

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Who this might be right for
Breast Cancer FemaleEndocrine Therapy
Hongmei Zheng, PhD 1,200
Large-scale testing (Phase 3)Study completedNCT03252431
What this trial is testing

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 393
Next Page